IL‐1 receptor antagonist plus pentoxifylline and zinc for severe alcohol‐associated hepatitisGyöngyi Szabó, Jennifer A. Cuthbert, Mack C. Mitchell et al.|Hepatology|2022Cited by 103
Biomarkers of Macrophage Activation and Immune Danger Signals Predict Clinical Outcomes in Alcoholic HepatitisBanishree Saha, Gyöngyi Szabó, Dávid Tornai et al.|Hepatology|2019Cited by 77
Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitisSamer Gawrieh, Ashutosh Barve, Raj Vuppalanchi et al.|Journal of Hepatology|2024Cited by 54
In vivo Bruton’s tyrosine kinase inhibition attenuates alcohol-associated liver disease by regulating CD84-mediated granulopoiesisPrashanth Thevkar Nagesh, Bruce Barton, Yeonhee Cho et al.|Science Translational Medicine|2024Cited by 8
A novel score of IL-13 and age predicts 90-day mortality in severe alcohol-associated hepatitis: A multicenter plasma biomarker analysisDávid Tornai, Gyöngyi Szabó, Mack C. Mitchell et al.|Hepatology Communications|2023Cited by 6